United Statesmedical

Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." Merck agreed to buy Terns Pharmaceuticals for $6.7 billion, giving the multinational company access to a promising new leukemia treatment as it faces the patent expiration of its bestselling cancer drug.

World Health Organization Chief Tedros Adhanom Ghebreyesus speaks to Bloomberg's Mishal Husain about the US stance on mRNA vaccine research funding. "I hope they will reconsider," he says on The Mishal Husain Show. He also talks about his relationship with US Health Secretary Robert F. Kennedy Jr., saying they "continue to speak to each other."